目的:比較不同層級醫院三高藥品重複用藥日數比率及其改善情形。方法:擷取2011 年第1 季至2013 年第2 季衛生福利部中央健康保險署網路公佈各醫院的各季三高(即降血壓、降血糖、及降血脂藥物)給藥日數重複率。利用探索性因素決定因素的個數,以組間均方和換算出新座標權重比例。以單因子變異數分析檢定不同層級醫院間的的差異,並利用標準化迴歸係數檢測其間改善程度。結果:三高重複用藥日數的比率,呈現地區醫院不如醫學中心及區域醫院。其改善情形:在血壓用藥方面,呈現出區域醫院優於地區醫院;在血糖及血脂用藥方面,也呈現出區域醫院及醫學中心優於地區醫院。結論:三高藥品重複用藥日數比率呈現明顯的改善,重複用藥在大型醫院電腦系統的協助下較具成效。
Objectives: We evaluated the degree of therapeutic duplication (TD) of medications in Taiwan hospitals for outpatients with hypertension, hyperglycemia, and dyslipidemia, and determined whether or not the clinical findings improved or became worse in the most recent 10 fiscal quarters. Methods: Data from the 1st quarter of 2011 to the 2nd quarter of 2013 of duplicate prescription rates of medications were retrieved from the Taiwan government-run National Health Insurance Department website. Exploratory factor analysis was used to determine the number of factors. Two periods of 3-type studied duplicate day ratios were used to construct a newly weighted and coordinated variable referring to the greatest ratio value of between-group to within-group in sum of mean squares of analysis of variance (ANOVA) to examine the differences between hospital levels. Standardized regression coefficients were used to investigate the data. Results: TD problems were significantly more serious in local hospitals than medical centers and regional hospitals. The reduction in TD for anti-hypertensive medications was significantly greater (p = 0.001) in regional hospitals than local hospitals. The reduction in TD for hypoglycemic and hypolipidemic medications was greater (p = 0.05) in medical centers and regional hospitals than local hospitals. Conclusions: Local hospitals did not improve as much as medical centers and regional hospitals, possibly because of differences in computerization.